Drug Resistance = Opportunity 
Posted by Carlos on May 17, 2011

Bloomberg has a good round up of several emerging pharmaceutical companies developing antibiotics. As the article notes, Big Pharma has largely moved away from antibiotic development for a number of commercial reasons. But, the unmet needs are still there, creating opportunities for product development.

This is good news, as the demand for novel antibiotics will only increase, especially as resistance remains a problem.

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.